Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Antigenics Inc (AGEN)  
$0.44 0.00 (0.00%) as of 4:30 Thu 4/11


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 381,510,000
Market Cap: 169.20(M)
Last Volume: 4,513,016 Avg Vol: 4,500,422
52 Week Range: $0.4435 - $2.04
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Agenus is a clinical-stage immuno-oncology (I-O) company engaged in the development of a pipeline of immune checkpoint antibodies, adoptive cell therapies and neoantigen cancer vaccines, to fight cancer and infections. Co.'s antibody candidates are balstilimab (an anti-PD-1 antibody) and zalifrelimab (an anti-CTLA-4 antibody), which are in Phase 2 trials as both a monotherapy (balstilimab) and combination therapy (balstilimab/zalifrelimab) for treatment of patients with second-line cervical cancer. Co. is also developing an anti-CTLA-4 antibody, botensilimab (also known as AGEN1181), which is designed to improve the magnitude of responses to first-generation anti-CTLA-4 molecules.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 500,000 525,000 525,000 525,000
Total Buy Value $324,050 $343,050 $343,050 $343,050
Total People Bought 1 2 2 2
Total Buy Transactions 1 2 2 2
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-02-01 2023-10-31 2023-05-02 2022-05-02

   
Records found: 186
  Page 5 of 8  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Wright Timothy Director   –       •      –    2018-03-31 4 OE $0.00 $0 D/D 15,915 17,581     -
   Valentine Karen Chief Legal Officer   •       –      –    2017-12-12 4 S $3.46 $28,921 D/D (8,358) 101,521     -
   Baysal Ozer Chief Commercial Officer   •       –      –    2017-12-12 4 S $3.46 $12,846 D/D (3,712) 58,790     -
   Klaskin Christine M VP, Finance   •       –      –    2017-12-12 4 S $3.46 $19,418 D/D (5,610) 64,333     -
   Buell Jennifer Chief Communications Officer   •       –      –    2017-12-12 4 S $3.46 $12,152 D/D (3,511) 35,656     -
   Duncan Alex Chief Technology Officer   •       –      –    2017-12-12 4 S $3.46 $22,651 D/D (6,546) 21,026     -
   Armen Garo H Chairman and CEO   •       –      –    2017-11-30 4 D $3.96 $1,188,000 D/D (300,000) 1,290,441     -
   Armen Garo H Chairman & CEO   •       –      –    2017-10-30 4/A B $3.61 $145,853 D/D 40,388 1,590,441 2.74     -
   Armen Garo H Chairman and CEO   •       –      –    2017-10-30 4 A $3.61 $145,853 D/D 40,388 1,590,441     -
   Armen Garo H Chairman & CEO   •       –      –    2017-10-27 4/A B $3.51 $209,262 D/D 59,612 1,550,053 2.74     -
   Armen Garo H Chairman and CEO   •       –      –    2017-10-27 4 A $3.51 $209,262 D/D 59,612 1,550,053     -
   Valentine Karen Chief Legal Officer   •       –      –    2017-10-09 4 A $3.59 $89,118 D/D 24,824 109,879     -
   Baysal Ozer Chief Commercial Officer   •       –      –    2017-10-09 4 A $3.59 $46,957 D/D 13,080 62,502     -
   Klaskin Christine M VP, Finance   •       –      –    2017-10-09 4 A $3.59 $37,447 D/D 10,431 69,943     -
   Buell Jennifer Chief Communications Officer   •       –      –    2017-10-09 4 A $3.59 $37,447 D/D 10,431 39,167     -
   Armen Garo H CEO and Chairman of the Board   •       –      –    2017-10-09 4 A $3.59 $258,358 D/D 71,966 1,362,407     -
   Duncan Alex Chief Technology Officer   •       –      –    2017-10-09 4 A $3.59 $48,189 D/D 13,423 27,572     -
   Buell Jennifer VP Research & External Affairs   •       –      –    2017-09-03 4 A $3.72 $16,275 D/D 4,375 28,736     -
   Duncan Alex Chief Technology OfficerOffice   •       –      –    2017-06-29 3 IO $0.00 $0 D/D 0 14,149     -
   Buell Jennifer VP Research & External Affairs   •       –      –    2017-06-29 3 IO $0.00 $0 D/D 0 24,361     -
   Klaskin Christine M VP, Finance   •       –      –    2017-04-19 4 D $3.39 $12,655 D/D (3,733) 59,512     -
   Klaskin Christine M VP, Finance   •       –      –    2017-04-19 4 A $3.39 $35,354 D/D 10,429 63,245     -
   Baysal Ozer Chief Business Officer   •       –      –    2017-04-19 4 D $3.39 $11,997 D/D (3,539) 49,422     -
   Baysal Ozer Chief Business Officer   •       –      –    2017-04-19 4 A $3.39 $44,334 D/D 13,078 52,961     -
   Valentine Karen Chief Legal Officer   •       –      –    2017-04-19 4 $3.39 $27,306 D/D 8,055 85,055     -
  186 Records found
  1  2  3  4  5  6  7  8   
  Page 5 of 8
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us